Citation Impact
Citing Papers
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
Multiple myeloma
2014
PROGNOSTIC FACTORS IN MULTIPLE MYELOMA
1999
Is P-Glycoprotein a Sufficient Marker for Multidrug Resistance in Vivo? Immunohistochemical Staining for P-Glycoprotein in Children and Adult Leukemia: Correlation with Clinical Outcome
1995
Cell kinetics of human brain tumors: In vivo study with bromodeoxyuridine and flow cytometry
1988
Clinical translation of angiogenesis inhibitors
2002 Standout
Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials
2012 Standout
Hyaluronan: from extracellular glue to pericellular cue
2004 Standout
Cell Biology of Ischemia/Reperfusion Injury
2012 Standout
Acute Effects of Nicotine Infusion on Platelets in Nicotine Users with Normal and Impaired Renal Function
2000 StandoutNobel
Thrombin generation as an acute effect of cigarette smoking
1994
Neurogenesis in the adult human hippocampus
1998 Standout
The biological and clinical significance of the KI‐67 growth fraction in multiple myeloma
1992
Angiogenesis in B Cell Lymphoproliferative Diseases. Biological and Clinical Studies
1995
Monoclonal Gammopathy of Undetermined Significance
2005
Review of 1027 Patients With Newly Diagnosed Multiple Myeloma
2003 Standout
Antitumor Activity of Thalidomide in Refractory Multiple Myeloma
1999 Standout
The Ki-67 protein: From the known and the unknown
2000 Standout
Mechanisms of Bone Metastasis
2004 Standout
Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part I: Historical perspectives, histochemical methods and cell kinetics
1995
BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ASPECTS OF THE MULTIDRUG TRANSPORTER
1999 Standout
Clinical Studies with Modulators of Multidrug Resistance
1995
Neue Ziele für die Photopharmakologie
2016 StandoutNobel
Tissue factor contributes to microvascular defects after focal cerebral ischemia.
1993
Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part I: Historical perspectives, histochemical methods and cell kinetics
1995
Radiosurgery for malignant meningioma: results in 22 patients
2000 StandoutNobel
Overexpression of the Receptor for Hyaluronan-Mediated Motility (RHAMM) Characterizes the Malignant Clone in Multiple Myeloma: Identification of Three Distinct RHAMM Variants
1999
Coronary Plaque Disruption
1995 Standout
High levels of interleukin-6 are associated with low tumor burden and low growth fraction in multiple myeloma
1994
Emerging Targets in Photopharmacology
2016 StandoutNobel
Plasma cell labeling index and beta 2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma [see comments]
1993
International Staging System for Multiple Myeloma
2005 Standout
Works of R Luoni being referenced
Expression of p170 protein in multiple myeloma: A clinical study
1992
Effects of acute smoking on the hemostatic system in humans
1988
Ras oncogene expression and DNA content in plasma cell dyscrasias: a flow cytofluorimetric study
1990
Proliferation kinetics of plasma cells and of normal haemopoietic cells in multiple myeloma
1987
Monoclonal Antibody Ki-67 as a Marker of Proliferative Activity in Monoclonal Gammopathies
1991
Changing clinical presentation of multiple myeloma
1991
Presenting features of monoclonal gammopathies: an analysis of 684 newly diagnosed cases
1993
Platelet function and thrombin activity in patients with recent cerebral transient ischemic attacks.
1987
Serum Thymidine Kinase and Beta-2 Microglobulin in Monoclonal Gammopathies
1987
In vivo administration of bromodeoxyuridine and flow cytometry for cell kinetic studies in human malignancies.
1987
Analysis of Human Myeloma Cell Population Kinetics
1986